From: Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life
Week 52
AQLQ Population
n (%)
SAL/FP
n = 158
FOR/BUD
n = 155
Deterioration in QoL (<0)
14 (9)
29 (19)
No Change/Improvement <MID (≥ 0 – <0.5)
32 (20)
26 (17)
At Least MID Improvement in QoL (≥ 0.5)
112(71)
100 (64)